Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A

Thrombosis Research

Volumn 123, Issue 6, 2009, Pages 895-901

  van Veen, Joost J ^a   Gatt, Alex ^a   Bowyer, Annette E ^a   Cooper, Peter C ^a   Kitchen, Steve ^a   Makris, Mike ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Endogenous thrombin potential; Global haemostasis; Haemophilia A; ROTEM; Thrombin generation; Thromboelastometry

Indexed keywords

BLOOD CLOTTING FACTOR 8; THROMBIN;

ARTICLE; BLOOD CLOTTING TEST; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEMATOLOGICAL PROCEDURES; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THROMBIN TIME; THROMBOELASTOMETRY;

BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; REFERENCE VALUES; THROMBELASTOGRAPHY; THROMBIN;

EID: 63049129790     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.09.011     Document Type: Article

References (23)

1. Walsh P.N., Rainsford S.G., and Biggs R. Platelet coagulant activities and clinical severity in haemophilia. Thromb Diath Haemorrh 29 3 (1973) 722-729
2. van den Berg H.M., Fischer K., Mauser-Bunschoten E.P., Beek F.J., Roosendaal G., van der Bom J.G., et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 112 3 (2001) 561-565
3. Hemker H.C., Giesen P., Al Dieri R., Regnault V., de Smedt E., Wagenvoord R., et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33 1 (2003) 4-15
4. Beltran-Miranda C.P., Khan A., Jaloma-Cruz A.R., and Laffan M.A. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 11 4 (2005) 326-334
5. Dargaud Y., Beguin S., Lienhart A., Al Dieri R., Trzeciak C., Bordet J.C., et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 93 3 (2005) 475-480
6. Lewis S.J., Stephens E., Florou G., Macartney N.J., Hathaway L.S., Knipping J., et al. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion. Br J Haematol 138 6 (2007) 775-782
7. Luddington R., and Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2 11 (2004) 1954-1959
8. van Veen J.J., Gatt A., Cooper P.C., Kitchen S., Bowyer A.E., and Makris M. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 19 3 (2008) 183-189
9. Dargaud Y., Luddington R., Gray E., Negrier C., Lecompte T., Petros S., et al. Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol 139 2 (2007) 303-309
10. Sorensen B., Johansen P., Christiansen K., Woelke M., and Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 1 3 (2003) 551-558
11. Sorensen B., and Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2 1 (2004) 102-110
12. Sorensen B., Ingerslev J., Sorensen B., and Ingerslev J. Thromboelastography and recombinant factor VIIa-hemophilia and beyond. [Review] [23 refs]. Semin Hematol 41 1 Suppl 1 (2004) 140-144
13. Sorensen B., and Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia 11 Suppl 1 (2005) 1-6
14. Barrowcliffe T.W. Methodology of the two-stage assay of FVIII. Scan J Haematol 41 (1984) 25-38 (Suppl)
15. Dargaud Y., Bordet J.C., Francillon S., and Negrier C. Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: Are these results really discordant?. Thromb Haemost 97 4 (2007) 675-676
16. Mann K.G., Brummel K., and Butenas S. What is all that thrombin for?. J Thromb Haemost 1 (2003) 1504-1514
17. Chantarangkul V., Clerici M., Bressi C., Giesen P.L., and Tripodi A. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 88 5 (2003) 547-554
18. Keularts I.M., Zivelin A., Seligsohn U., Hemker H.C., and Beguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 85 6 (2001) 1060-1065
19. Hackeng T.M., Sere K.M., Tans G., and Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. PNAS 103 9 (2006) 3106-3111
20. Sere K.M., Rosing J., Hackeng T.M., Sere K.M., Rosing J., and Hackeng T.M. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.[see comment]. Blood 104 12 (2004) 3624-3630
21. van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, MakrisM. The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents. Int J Lab Hematol in press, doi:10.1111/j.1751-553X.2007.01022.x.
22. Tappenden K.A., Gallimore M.J., Evans G., Mackie I.J., and Jones D.W. Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism. Br J Haematol 139 1 (2007) 106-112
23. E. Gray, Hemostasis and malignancy 2007 SSC subcommitte minutes. http://www.med.unc.edu/isth/ssc/07sscminutes/07hemo_malignancy.htm 2007; accessed 25/12/2007, 11.43.